Daily organ tracking in intensity-modulated radiotherapy of prostate cancer using an electronic portal imaging device with a dose saving acquisition mode

Radiotherapy and Oncology

Volumn 79, Issue 1, 2006, Pages 101-108

  Vetterli, Daniel ^a   Thalmann, Sandrine ^b   Behrensmeier, Frank ^b   Kemmerling, Ludger ^a   Born, Ernst J ^a   Mini, Roberto ^a   Greiner, Richard H ^b   Aebersold, Daniel M ^b  

^a Division of Medical Radiation Physics

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

EPID; IMRT; Organ tracking; Prostate cancer

Indexed keywords

ACCURACY; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEVICE; HUMAN; IMAGING; INTENSITY MODULATED RADIATION THERAPY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; QUALITY CONTROL; RADIATION BEAM; RADIATION DOSE; RADIATION DOSE FRACTIONATION; TREATMENT PLANNING;

ELECTRONICS, MEDICAL; GOLD; HUMANS; MALE; PROSTATE; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; TREATMENT OUTCOME;

EID: 33646184319     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2006.03.005     Document Type: Article

References (22)

1. Alasti H., Petric M.P., Catton C.N., and Warde P.R. Portal imaging for evaluation of daily on-line setup errors and off-line organ motion during conformal irradiation of carcinoma of the prostate. Int J Radiat Oncol Biol Phys 49 (2001) 869-884
2. Aubry J.F., Beaulieu L., Girouard L.M., et al. Measurements of intrafraction motion and interfraction and intrafraction rotation of prostate by three-dimensional analysis of daily portal imaging with radiopaque markers. Int J Radiat Oncol Biol Phys 60 (2004) 30-39
3. Beaulieu L., Girouard L.M., Aubin S., et al. Performing daily prostate targeting with a standard V-EPID and an automated radio-opaque marker detection algorithm. Radiother Oncol 73 (2004) 61-64
4. Bos L.J., van der Geer J., van Herk M., Mijnheer B.J., Lebesque J.V., and Damen E.M. The sensitivity of dose distributions for organ motion and set-up uncertainties in prostate IMRT. Radiother Oncol 76 (2005) 18-26
5. Chandra A., Dong L., Huang E., et al. Experience of ultrasound-based daily prostate localization. Int J Radiat Oncol Biol Phys 56 (2003) 436-447
6. Chung P.W., Haycocks T., Brown T., et al. On-line aSi portal imaging of implanted fiducial markers for the reduction of interfraction error during conformal radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 60 (2004) 329-334
7. Ciernik I.F., Baumert B.G., Egli P., Glanzmann C., and Lutolf U.M. On-line correction of beam portals in the treatment of prostate cancer using an endorectal balloon device. Radiother Oncol 65 (2002) 39-45
8. Dehnad H., Nederveen A.J., van der Heide U.A., van Moorselaar R.J., Hofman P., and Lagendijk J.J. Clinical feasibility study for the use of implanted gold seeds in the prostate as reliable positioning markers during megavoltage irradiation. Radiother Oncol 67 (2003) 295-302
9. Langen K.M., and Jones D.T. Organ motion and its management. Int J Radiat Oncol Biol Phys 50 (2001) 265-278
10. Leibel S.A., Fuks Z., Zelefsky M.J., et al. Technological advances in external-beam radiation therapy for the treatment of localized prostate cancer. Semin Oncol 30 (2003) 596-615
11. Little D.J., Dong L., Levy L.B., Chandra A., and Kuban D.A. Use of portal images and BAT ultrasonography to measure setup error and organ motion for prostate IMRT: implications for treatment margins. Int J Radiat Oncol Biol Phys 56 (2003) 1218-1224
12. Manser P., Treier R., Riem H., et al. Dose response of an A-Si:H EPID on static and dynamic photon beams. Med Phys 29 (2002) 1269
13. Nederveen A.J., Lagendijk J.J., and Hofman P. Feasibility of automatic marker detection with an a-Si flat-panel imager. Phys Med Biol 46 (2001) 1219-1230
14. Serago C.F., Chungbin S.J., Buskirk S.J., Ezzell G.A., Collie A.C., and Vora S.A. Initial experience with ultrasound localization for positioning prostate cancer patients for external beam radiotherapy. Int J Radiat Oncol Biol Phys 53 (2002) 1130-1138
15. Shimizu S., Shirato H., Kitamura K., et al. Use of an implanted marker and real-time tracking of the marker for the positioning of prostate and bladder cancers. Int J Radiat Oncol Biol Phys 48 (2000) 1591-1597
16. Shirato H., Oita M., Fujita K., et al. Three-dimensional conformal setup (3D-CSU) of patients using the coordinate system provided by three internal fiducial markers and two orthogonal diagnostic X-ray systems in the treatment room. Int J Radiat Oncol Biol Phys 60 (2004) 607-612
17. Teh B.S., Mai W.Y., Uhl B.M., et al. Intensity-modulated radiation therapy (IMRT) for prostate cancer with the use of a rectal balloon for prostate immobilization: acute toxicity and dose-volume analysis. Int J Radiat Oncol Biol Phys 49 (2001) 705-712
18. van Lin E.N., van der Vight L.P., Witjes J.A., Huisman H.J., Leer J.W., and Visser A.G. The effect of an endorectal balloon and off-line correction on the interfraction systematic and random prostate position variations: a comparative study. Int J Radiat Oncol Biol Phys 61 (2005) 278-288
19. Vetterli D., Riem H., Aebersold D.M., et al. Introduction of a novel dose saving acquisition mode for the PortalVision aS500 EPID to facilitate on-line patient setup verification. Med Phys 31 (2004) 828-831
20. Vigneault E., Pouliot J., Laverdiere J., Roy J., and Dorion M. Electronic portal imaging device detection of radioopaque markers for the evaluation of prostate position during megavoltage irradiation: a clinical study. Int J Radiat Oncol Biol Phys 37 (1997) 205-212
21. Wachter S., Gerstner N., Dorner D., et al. The influence of a rectal balloon tube as internal immobilization device on variations of volumes and dose-volume histograms during treatment course of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 52 (2002) 91-100
22. Wu J., Haycocks T., Alasti H., et al. Positioning errors and prostate motion during conformal prostate radiotherapy using on-line isocentre set-up verification and implanted prostate markers. Radiother Oncol 61 (2001) 127-133